hVIVO

HVO: 19.25 -0.25 (-1.28%) delayed: 17 Sep 2019, 16:57

Trade now
Bid Price 18.75 High Price 19.01
Ask Price 19.75 Low Price 18.55
Open Price 19.01 Spread 5.06%
Prev Close 19.25 Volume 34,740

hVIVO Share Price

Intraday
Historic - 6 months
>> Advanced hVIVO Charts >>

hVIVO Share Price Information

Name hVIVO
Epic HVO
Sector Biotechnology
ISIN GB00B6ZM0X53
Activites hVIVO plc (formerly Retroscreen Virology Group plc) is pioneering a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases. Leveraging human disease models in flu, RSV, HRV and respiratory indications, the hVIVO platform captures disease in motion, illuminating the entire disease life cycle from healthy to sick and back to health. Based in the UK, market leader hVIVO has conducted more than 50 clinical studies and inoculated over 2500 volunteers.
Index n/a
Latest Share Price (p) 19.25 Net Gearing (%) -8.74
Market Capitalisation (£m) 16.21 Gross Gearing (%) 38.61
Shares in issue (m) 83.12 Debt Ratio 0.12
P/E Ratio -0.92 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.63
Dividend Yield (%) 0.00 Price to book value 0.94
Dividend Cover 0.00 ROCE (%) -108.70
Earning per share (p) -21.30 EPS Growth (%) -29.09
52-week high / low (p) 75.00 / 18.13 DPS Growth (%) n/a

hVIVO Broker Views

Date Broker Recommendation Price Old Target Price New Target Price Notes
20 Sep Numis Buy 19.25 80.00 - Reiterates
18 Jun Numis Buy 19.25 55.00 - Reiterates
06 Jun Numis Buy 19.25 55.00 - Upgrades
19 Apr Numis Hold 19.25 80.00 55.00 Downgrades
21 Sep Numis Hold 19.25 - 80.00 Downgrades
>> More hVIVO Broker Views >>

hVIVO Director Deals

Date Director Type Volume / Price Trade Value
02 Jul 2019 Jim Winschel Buy 19,753 @ 20.25p £3,999.98
01 Apr 2019 Jim Winschel Buy 15,772 @ 25.36p £3,999.78
04 Jan 2019 Jim Winschel Buy 14,115 @ 28.34p £4,000.19
08 Oct 2018 Jim Winschel Buy 6,420 @ 62.30p £3,999.66
10 Aug 2018 Dr Trevor Phillips Buy 23,500 @ 65.00p £15,275.00
>> More hVIVO Director Deals >>

hVIVO News

>> More hVIVO News >>